What is ProKidney Corp (PROK)?
ProKidney Corp is a biotechnology company focused on developing therapies for kidney diseases. The company engages in research and development activities aimed at discovering and advancing treatments that address unmet medical needs in nephrology. ProKidney's pipeline includes drug candidates targeting conditions such as chronic kidney disease and related complications. The company utilizes scientific expertise and innovative technologies to identify potential therapeutic agents and progress them through clinical development stages. Its operations encompass preclinical research, clinical trials, regulatory interactions, and strategic partnerships. ProKidney aims to improve patient outcomes by providing novel treatment options that slow disease progression and enhance kidney function. The company's approach integrates translational science and patient-centered research to address challenges in kidney health.
ProKidney Corp Stock Price Today: Live Overview
The price today is shaped by the latest trading range, with Ceragon Networks Ltd currently at $1.86. Throughout the session, it has moved between $1.81 and $1.88, showing a daily change of +1.676%.
FAQ: ProKidney Corp (PROK)
What is the current price of PROK stock?
The last traded price is $1.86.
Does PROK pay dividends?
ProKidney Corp does not pay dividends.
Does PROK have a formal corporate presence or regional headquarters in the UAE?
ProKidney Corp does not have an official UAE office or subsidiary and operates through partners.
What is PROK best known for?
The company is most famous for developing innovative therapies for kidney diseases.
What assets are typically shown together with PROK?
Commonly shown alongside PROK: JPMorgan Ultra-Short Income ETF, SoftBank Group Corp., Universal Electronics Inc
Latest shares articles



